Chinatsu Sakata-Sakurai

Company: Astellas Pharma

Job title: Vice President, Primary Focus Lead, Targeted Protein Degradation, Astellas

Seminars:

Targeting ‘Undruggable’ Targets: Pioneering Novel Applications of Heterobifunctional Degrade 9:45 am

Astellas’ long-term innovation strategy in Targeted Protein Degradation Learnings from the discovery and development of ASP3082 Accelerating progress through an integrated R&D approach and strategic collaborationsRead more

day: Day 1 - Until 10:15